CLASS II Drug recall · Reported 8 Nov 2023 · FDA Enforcement Report

Strong Iodine Solution U.S.P. (Lugol's Solution) (Iodine 5%) recalled

Safecor Health is recalling Strong Iodine Solution U.S.P. (Lugol's Solution) (Iodine 5%), distributed nationwide in the US. The recall was initiated on 19 Oct 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot # 21A0073, Exp 11/30/2023; 21A0091, Exp. 12/31/2023; 21A0103, Exp 01/31/2024; 21A0135, Exp 03/31/2024; 22A0011, Exp 06/30/2024; 22A0019, Exp 07/31/2024; 22A0057, Exp 09/30/2024; 22A0083, Exp 11/30/2024; 22A0104, Exp 12/31/2024; 22A0110, Exp 01/31/2025; 22A0150, Exp 03/31/2025; 23A0007, Exp 06/30/2025; 23A0041, Exp 09/30/2025; 23A0045, Exp 11/30/2025; 23A0058, Exp 11/30/2025; 23A0067, Exp 11/30/2025; 23A0080, Exp 12/31/2025; 23A0090, Exp 01/31/2026
NDC48433-230
UPC0348433230152
Quantity recalled166,022 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0082-2024
FDA event ID
93220
Recalling firm
Safecor Health, Woburn, MA
Manufacturer
Safecor Health, LLC
Classification
Class II
Status
Terminated
Recall initiated
19 Oct 2023
FDA classified
1 Nov 2023
Reported
8 Nov 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter

Timeline

19 Oct 2023Recall initiated by company
1 Nov 2023Classified by FDA+13 days
8 Nov 2023Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

CGMP Deviations: Recall due to the absence of USP CGMP compendial requirements.

Product as listed by the FDA

Strong Iodine Solution U.S.P. (Lugol's Solution) (Iodine 5%), 14 mL Glass Dropper bottle in box, RX only, Safecor Health, LLC, Woburn, MA 01801. NDC# 48433-230-15

Where it was distributed

Distributed Nationwide in the USA

Nationwide

Questions about this recall

Why was it recalled?

CGMP Deviations: Recall due to the absence of USP CGMP compendial requirements.

Which lots are affected?

Lot # 21A0073, Exp 11/30/2023; 21A0091, Exp. 12/31/2023; 21A0103, Exp 01/31/2024; 21A0135, Exp 03/31/2024; 22A0011, Exp 06/30/2024; 22A0019, Exp 07/31/2024; 22A0057, Exp 09/30/2024; 22A0083, Exp 11/30/2024; 22A0104, Exp 12/31/2024; 22A0110, Exp 01/31/2025; 22A0150, Exp 03/31/2025; 23A0007, Exp 06/30/2025; 23A0041, Exp 09/30/2025; 23A0045, Exp 11/30/2025; 23A0058, Exp 11/30/2025; 23A0067, Exp 11/30/2025; 23A0080, Exp 12/31/2025; 23A0090, Exp 01/31/2026

Where was it sold?

Distributed Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Safecor Health

All 30